Literature DB >> 19497611

Prospective analysis of risk factors and distribution of venous thromboembolism in the population-based Malmö Thrombophilia Study (MATS).

Nazim Isma1, Peter J Svensson, Anders Gottsäter, Bengt Lindblad.   

Abstract

BACKGROUND: Despite venous thromboembolism (VTE) being a major cause of morbidity and mortality, there is still limited information on its prevalence and incidence in the general population.
OBJECTIVE: To evaluate risk factors, distribution and epidemiology of VTE in the Malmö area with 280,000 inhabitants.
METHODS: Patients diagnosed with VTE at Malmö University Hospital in 1998-2006 were invited to a prospective population-based study. Blood sampling and a questionnaire study could be performed in 70% of patients. Remaining 30% were excluded due to language problems, dementia, other severe disease, or unwillingness to participate.
RESULTS: During 1998-2006 1140 VTE patients (559 men [49%, age 62+/-16 years] and 581 women [51%, age 61+/-20 years]) were included. Deep venous thrombosis (DVT) occurred in 882 (77%), pulmonary embolism (PE) in 330 (29%), and both DVT and PE in 72 (6%). The most common acquired risk factors among VTE patients were hormone therapy (24% of female DVT patients and 19% of female PE patients), immobilisation (17% of DVT patients and 18% of PE patients), previous surgery (13% of DVT patients and 19% of PE patients), and concomitant malignant disease (12% of DVT patients and 11% of PE patients). A positive family history for VTE was obtained from 25% of DVT patients and 22% of PE patients. Yearly incidences of VTE, DVT and PE in Malmö were 66, 51, and 19/100.000, respectively.
CONCLUSION: Hormone therapy, immobilisation, previous surgery and concomitant malignancy were the most common acquired risk factors among VTE patients in this population-based study. The VTE-incidence was lower than in earlier epidemiological studies.

Entities:  

Mesh:

Year:  2009        PMID: 19497611     DOI: 10.1016/j.thromres.2009.04.022

Source DB:  PubMed          Journal:  Thromb Res        ISSN: 0049-3848            Impact factor:   3.944


  20 in total

1.  Transforming growth factor (TGF)-β levels and unprovoked recurrent venous thromboembolism.

Authors:  Ashfaque A Memon; Kristina Sundquist; Xiao Wang; Peter J Svensson; Jan Sundquist; Bengt Zöller
Journal:  J Thromb Thrombolysis       Date:  2014-10       Impact factor: 2.300

2.  Time trends in incidence rates of venous thromboembolism in a large cohort recruited from the general population.

Authors:  Nadia Arshad; Trond Isaksen; John-Bjarne Hansen; Sigrid K Brækkan
Journal:  Eur J Epidemiol       Date:  2017-03-17       Impact factor: 8.082

3.  Venous thromboembolism after major orthopaedic surgery: a population-based cohort study.

Authors:  Davide Imberti; Cosetta Bianchi; Antonella Zambon; Andrea Parodi; Luca Merlino; Massimo Gallerani; Giovanni Corrao
Journal:  Intern Emerg Med       Date:  2011-03-26       Impact factor: 3.397

4.  Homozygous factor V Leiden and double heterozygosity for factor V Leiden and prothrombin mutation.

Authors:  Ymir Saemundsson; Signý Vala Sveinsdottir; Henrik Svantesson; Peter J Svensson
Journal:  J Thromb Thrombolysis       Date:  2013-10       Impact factor: 2.300

5.  Fat mass and obesity-associated gene rs9939609 polymorphism is a potential biomarker of recurrent venous thromboembolism in male but not in female patients.

Authors:  Abrar Ahmad; Ashfaque A Memon; Jan Sundquist; Peter J Svensson; Bengt Zöller; Kristina Sundquist
Journal:  Gene       Date:  2018-01-09       Impact factor: 3.688

6.  Polymorphisms in PARK2 and MRPL37 are associated with higher risk of recurrent venous thromboembolism in a sex-specific manner.

Authors:  Kristina Sundquist; Abrar Ahmad; Peter J Svensson; Bengt Zöller; Jan Sundquist; Ashfaque A Memon
Journal:  J Thromb Thrombolysis       Date:  2018-08       Impact factor: 2.300

7.  MR Venography for the Assessment of Deep Vein Thrombosis in Lower Extremities with Varicose Veins.

Authors:  Kiyoshi Tamura; Hideki Nakahara
Journal:  Ann Vasc Dis       Date:  2014-12-25

8.  Idiopathic deep venous thrombosis and arterial endothelial dysfunction in the elderly.

Authors:  Gianluigi Mazzoccoli; Andrea Fontana; Massimo Grilli; Mariangela Pia Dagostino; Massimiliano Copetti; Fabio Pellegrini; Gianluigi Vendemiale
Journal:  Age (Dordr)       Date:  2011-05-20

9.  Socioeconomic factors and concomitant diseases are related to the risk for venous thromboembolism during long time follow-up.

Authors:  Nazim Isma; Juan Merlo; Henrik Ohlsson; Peter J Svensson; Bengt Lindblad; Anders Gottsäter
Journal:  J Thromb Thrombolysis       Date:  2013-07       Impact factor: 2.300

10.  Thrombomodulin gene c.1418C>T polymorphism and risk of recurrent venous thromboembolism.

Authors:  Abrar Ahmad; Kristina Sundquist; Bengt Zöller; Peter J Svensson; Jan Sundquist; Ashfaque A Memon
Journal:  J Thromb Thrombolysis       Date:  2016-07       Impact factor: 2.300

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.